- Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell TransplantationHuang, Fen; Du, Jing; Lv, Pinjing; Yang, Kaibo; Fan, Zhiping; Xuan, Li; Sun, Jing; Xu, Na; Liu, Hui; Shi, Pengcheng; Li, Xiaofang; Xu, Jun; Wang, Zhixiang; Wang, Pu; Yao, Xiang; Chen, Ye; Liu, Qifa65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Microbiome Signature ofnon-Responder to Fecal Microbiota Transplantation in Patient with Steroid-Refractory Chronic Graft-Versus-Host Disease after Hematopoietic Stem Cell TransplantationYang, Kaibo; Huang, Fen; Du, Jing; Xuan, Li; Xu, Na; Fan, Zhiping; Liu, Qifa65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Increased Circulating 2-Methylbutyrate Following Fecal Microbiota Transplantation in Patients with Refractory-Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationDu, Jing; Huang, Fen; Yang, Kaibo; Xu, Na; Fan, Zhiping; Xuan, Li; Liu, Qifa65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
會議論文
Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Acute and Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation
1被引27閱讀
